ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 218 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $232,962 | +29.5% | 26,383 | +12.1% | 0.01% | +16.7% |
| Q4 2022 | $179,846 | +13.1% | 23,540 | +5.1% | 0.01% | +20.0% |
| Q3 2022 | $159,000 | -19.7% | 22,400 | -8.5% | 0.01% | -9.1% |
| Q2 2022 | $198,000 | -24.4% | 24,476 | +29.6% | 0.01% | -21.4% |
| Q1 2022 | $262,000 | -38.9% | 18,879 | +23.4% | 0.01% | -46.2% |
| Q4 2021 | $429,000 | -11.2% | 15,300 | +7.8% | 0.03% | -3.7% |
| Q3 2021 | $483,000 | -33.0% | 14,197 | -19.5% | 0.03% | -30.8% |
| Q2 2021 | $721,000 | +5.3% | 17,638 | +3.7% | 0.04% | 0.0% |
| Q1 2021 | $685,000 | -37.5% | 17,004 | -8.2% | 0.04% | -50.6% |
| Q4 2020 | $1,096,000 | -31.9% | 18,528 | -44.0% | 0.08% | +51.9% |
| Q3 2020 | $1,609,000 | – | 33,081 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 1,014,860 | $14,086,000 | 3.47% |
| Triatomic Management LP | 297,048 | $4,123,000 | 3.35% |
| Diametric Capital, LP | 265,000 | $3,678,000 | 2.03% |
| Matrix Capital Management Company, LP | 11,572,590 | $160,628,000 | 1.93% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $416,313,000 | 1.68% |
| TIGER MANAGEMENT L.L.C. | 589,311 | $8,180,000 | 1.35% |
| Aristotle Atlantic Partners, LLC | 759,412 | $10,541,000 | 0.65% |
| Casdin Capital, LLC | 1,000,000 | $13,880,000 | 0.62% |
| Pier Capital, LLC | 339,541 | $4,713,000 | 0.60% |
| Leeward Financial Partners, LLC | 68,504 | $951,000 | 0.59% |